Office of Technology Transfer & Intellectual Property Management
The Office of Technology Transfer & Intellectual Property Management serves our investigators by matching technologies and research with industry needs. The work of our investigators involves areas including cancer, neurodegenerative diseases, gene therapy, neurobiology of pain, organ transplantation, AIDS, and other infectious diseases.
The technology transfer office handles legal matters involved in intellectual property, evaluates the invention's economic prospects, and explores opportunities for collaboration and commercialization.
The research conducted at California Pacific Medical Center brings new developments from the lab to the clinic. Exceptional patient care is integrated with extensive research, dedicated to education, research and to the people of California.
Active patents managed by CPMCRI include:
Prognostic methods for breast cancer - Shanaz Dairkee
Systemic anti-PECAM-1antibody broadly suppresses tumor metastasis - Robert Debs
Methods and compositions for non-viral, in-vivo gene delivery - Robert Debs
Metastasis inhibitor gene and related methods – Robert Debs
Novel use of ribozymes to block gene expression – Robert Debs
Cannabidiol as an inhibitor of cancer invasion and metastasis through Id-1 down regulation – Sean McAllister and Pierre Desprez
Cannabinoid derivatives - Sean McAllister
Methods and compositions for treating cancer – Sean McAllister
Targeting of diseased cells through cell-surface protein modifications – John Muschler
Camptothecin derivatives - Li-Xi Yang
Nitrogen-based camptothecin derivatives - Li-Xi Yang
Colchicine derivatives - Li-Xi Yang
Podophyllotoxin derivatives - Li-Xi Yang
Nitrogen-based homocamptothecin derivatives - Li-Xi Yang
Camptothecin derivatives as chemoradiosensitizing agents - Li-Xi Yang
Dynamic genome self-test kit – Garret Yount
Other recent developments include:
Dairkee SH, Seok J, Champion S, Sayeed A, Mindrinos M, Xiao W, Davis RW, Goodson WH. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.Opens new window
Sean D. McAllister and Pierre-Yves Desprez: Cannabidiol inhibiting breast cancer progression in culture